Central nervous system (CNS) involvement has an adverse impact on survival in newly diagnosed adult acute lymphoblastic leukemia (ALL) assessed by flow cytometry

References

• Reman O, Pigneux A, Huguet F, et al. Central nervous system involvement in adult acute lymphoblastic leukemia (ALL) at diagnosis and/or at first relapse: results from the GET-LALA group. Blood. 2007;110(11):4326–4326.
   Web of Science ®Google Scholar
• Del Principe MI, Buzzatti E, Piciocchi A, et al. Clinical significance of occult central nervous system disease in adult acute lymphoblastic leukemia. A multicenter report from the campus all network. Haematol. 2019;106(1):39–45.
   Web of Science ®Google Scholar
• Hoelzer D, Bassan R, Dombret H. Acute lymphoblastic leukemia in adult patients: ESMO clinical practice guidelines for diagnostis, treatment and follow up. Ann Oncol. 2016;27(suppl 5):v69–v82.
   PubMed Web of Science ®Google Scholar
• Brown P, Shah B, Advani A, et al. 2020. Acute lymphoblastic leukemia. NCCN Guidelines version 2.2020. Available from: https://www.nccn.org/professionals/physician_gls/pdf/all.pdf
   Google Scholar
• Tawfik B, Brown L, Fuda F, et al. Utility and proposed algorithm of CSF flow cytometry in hematologic malignancies. Ann Hematol. 2018;97(9):1707–1716.
   PubMed Web of Science ®Google Scholar
• Jaime-Pérez J, Borrego-López M, Jiménez-Castillo R, et al. Comparison of conventional cytomorphology, flow cytometry immunophenotyping, and automated cell counting of CSF for detection of CNS involvement in acute lymphoblastic leukemia. Int J Lab Hematol. 2018;40(2):169–174.
   PubMed Web of Science ®Google Scholar
• Subirá D, Castañón S, Román A, et al. Flow cytometry and the study of central nervous disease in patients with acute leukaemia. Br J Haematol. 2001;112(2):381–384.
   PubMed Web of Science ®Google Scholar
• Lenk L, Alsadeq A, Schewe DM. Involvement of the central nervous system in acute lymphoblastic leukemia: opinions on molecular mechanisms and clinical implications based on recent data. Cancer Metastasis Rev. 2020;39(1):173–187.
   PubMed Web of Science ®Google Scholar
• Levinsen M, Taskinen M, Abrahamsson J, et al. Clinical features and early treatment response of central nervous system involvement in childhood acute lymphoblastic leukemia. Pediatr Blood Cancer. 2014;61(8):1416–1421.
   PubMed Web of Science ®Google Scholar
• Larson RA. Managing CNS disease in adults with acute lymphoblastic leukemia. Leuk Lymphoma. 2018;59(1):3–13.
   PubMed Web of Science ®Google Scholar
• Cancela P, Murao M, Assumpção J, et al. Immunophenotyping of the cerebrospinal fluid as a prognostic factor at diagnosis of acute lymphoblastic leukemia in children and adolescents. Pediatr Hematol Oncol. 2017;34(2):53–65.
   PubMed Web of Science ®Google Scholar
• Frishman-Levy L, Izraeli S. Advances in understanding the pathogenesis of CNS acute lymphoblastic leukaemia and potential for therapy. Br J Haematol. 2017;176(2):157–167.
   PubMed Web of Science ®Google Scholar
• Garcia K, Stevenson P, Cherian S, et al. Multiparameter flow cytometry (MFC) of cerebrospinal fluid (CSF) from adults receiving hypercvad for acute lymphoblastic leukemia/lymphoma (ALL) identifies patients at higher risk of central nervous system (CNS) relapse: a single-center retrospective analysis. Blood. 2020;136(Supplement 1):28–30.
   Google Scholar
• Yang W, Xiaojuan Y, Zhang C, et al. The correlation studies between central nervous system involvement by flow cytometry and the prognosis of children acute lymphoblastic leukemia: a single chinese center's experience by Cclg- ALL. Blood. 2017;130(Supplement 1):1293.
   Google Scholar
• Baljevic M, Kantarjian H, Thomas D, et al. Incidence and outcome in adults with acute lymphoblastic leukemia with primary central nervous system involvement. Blood. 2013;122(21):2639–2639.
   Google Scholar
• Levinsen M, Marquart HV, Groth-Pedersen L, et al. Leukemic blasts are present at low levels in spinal fluid in one-third of childhood acute lymphoblastic leukemia cases. Pediatr Blood Cancer. 2016;63(11):1935–1942.
   PubMed Web of Science ®Google Scholar
• Rassi F, Mitri Z, Heffner L, et al. Cerebrospinal fluid flow cytometry in acute lymphoblastic leukemia/lymphoma: is it beneficial? Blood. 2012;120(21):2576.
   Google Scholar
• Cerello Chapchap E, Feres C, Cameirão Bento L, et al. Central nervous system (CNS) infiltration assessment using cerebrospinal fluid flow cytometry in hematologic malignancies: a single center retrospective analysis of clinical outcomes. Blood. 2019;134(Supplement_1):5773.
   Web of Science ®Google Scholar
• Nagafuji K, Miyamoto T, Eto T, et al. Minimal residual disease (MRD) status after induction therapy is a strong prognostic factor in the treatment of adult Ph (-) acute lymphoblastic leukemia (ALL): results of a prospective study (ALL MRD2008 study). Blood. 2018;132(Supplement 1):3970.
   Web of Science ®Google Scholar
• Thastrup V, Marquart H, Levinsen M, et al. Central nervous system involvement detected by flow cytometry is a risk factor for relapse in childhood acute lymphoblastic leukemia. Blood. 2018;132(Supplement 1):657–657.
   Web of Science ®Google Scholar
• Mitri Z, Siddiqui MT, El Rassi F, et al. Sensitivity and specificity of cerebrospinal fluid flow cytometry for the diagnosis of leukemic meningitis in acute lymphoblastic leukemia/lymphoma. Leuk Lymphoma. 2014;55(7):1498–1500.
   PubMed Web of Science ®Google Scholar
• Tang J, Yu J, Cai J, et al. Prognostic factors for CNS control in children with acute lymphoblastic leukemia treated without cranial irradiation. Blood. 2021; 2020010438.
   Google Scholar
• Beldjord K, Chevret S, Asnafi V, et al. Oncogenetics and minimal residual disease are independent outcome predictors in adult patients with acute lymphoblastic leukemia. Blood. 2014;123(24):3739–3749.
   PubMed Web of Science ®Google Scholar
• Quijano S, López AM, Sancho J, et al. Identification of leptomeningeal disease in aggressive B-cell non-Hodgkin’s lymphoma: improved sensitivity of flow cytometry. J Clin Oncol. 2009;27(9):1462–1469.
   PubMed Web of Science ®Google Scholar
• Wilson W, Bromberg J, Stetler-Stevenson M, et al. Detection and outcome of occult leptomeningeal disease in diffuse large B-cell lymphoma and Burkitt lymphoma. Haematologica. 2014;99(7):1228–1235.
   PubMed Web of Science ®Google Scholar
• Muslimani A, Kizilbash S, Jaiyesimi I, et al. Evaluation of the diagnostic utility of cerebral spinal fluid (CSF) flow cytometry (FC) in detection of central nervous system (CNS) involvement by hematological malignancy. Blood. 2010;116(21):3837.
   Web of Science ®Google Scholar
• Münch V, Trentin L, Herzig J, et al. Central nervous system involvement in acute lymphoblastic leukemia is mediated by vascular endothelial growth factor. Blood. 2017;130(5):643–654.
   PubMed Web of Science ®Google Scholar
• Del Principe M, Gatti A, Johansson U, et al. ESCCA/ISCCA protocol for the analysis of cerebrospinal fluid by multiparametric flow-cytometry in hematological malignancies. Cytometry B Clin Cytom. 2021;100(3):269–281.
   PubMed Web of Science ®Google Scholar
• Pui CH, Thiel E. Central nervous system disease in hematologic malignancies: historical perspective and practical applications. Semin Oncol. 2009;36(4 Suppl 2):S2–S16.
   PubMed Web of Science ®Google Scholar
• Sancho JM, Ribera JM, Oriol A, et al. Central nervous system recurrence in adult patients with acute lymphoblastic leukemia: frequency and prognosis in 467 patients without cranial irradiation for prophylaxis. Cancer. 2006;106(12):2540–2546.
   PubMed Web of Science ®Google Scholar
• Del Principe M, Buzzati E, Forghieri F, et al. Clinical significance of occult central nervous system disease in adult ACUTE lymphoblastic leukemia. a multicenter, report from the campus ALL/Gimema network. Blood. 2018;132(Supplement 1):658.
   PubMed Web of Science ®Google Scholar
• Alfayez M, Kantarjian H, Short N, et al. Safety and efficacy of blinatumomab in patients with central nervous system (CNS) disease: a single institution experience. Blood. 2018;132(Supplement 1):2702–2702.
   Web of Science ®Google Scholar
• DeVita VT, Jr, Chu E. A history of cancer chemotherapy. Cancer Res. 2008;68(21):8643–8653.
   PubMed Web of Science ®Google Scholar
• Pehlivan KC, Duncan BB, Lee DW. CAR-T cell therapy for acute lymphoblastic leukemia: transforming the treatment of relapsed and refractory disease. Curr Hematol Malig Rep. 2018;13(5):396–406.
   PubMed Web of Science ®Google Scholar
• Zhou F, Wen Y, Jin R, et al. New attempts for central nervous infiltration of pediatric acute lymphoblastic leukemia. Cancer Metastasis Rev. 2019;38(4):657–671.
   PubMed Web of Science ®Google Scholar
• Kantarjian H, Stein A, Gökbuget N, et al. Blinatumomab versus chemotherapy for advanced acute lymphoblastic leukemia. N Engl J Med. 2017;376(9):836–847.
   PubMed Web of Science ®Google Scholar
• Aldoss I, Song J, Stiller T, et al. Correlates of resistance and relapse during blinatumomab therapy for relapsed/refractory acute lymphoblastic leukemia. Am J Hematol. 2017;92(9):858–865.
   PubMed Web of Science ®Google Scholar
• Maude SL, Laetsch TW, Buechner J, et al. Tisagenlecleucel in children and young adults with B-cell lymphoblastic leukemia. N Engl J Med. 2018;378(5):439–448.
   PubMed Web of Science ®Google Scholar
• Park JH, Rivière I, Gonen M, et al. Long-term follow-up of CD19 CAR therapy in acute lymphoblastic leukemia. New Eng J Med. 2019;378(5):449–459.
   Web of Science ®Google Scholar
• Gaudichon J, Jakobczyk H, Debaize L, et al. Mechanisms of extramedullary relapse in acute lymphoblastic leukemia: reconciling biological concepts and clinical issues. Blood Rev. 2019;36:40–56.
   PubMed Web of Science ®Google Scholar
• Muench V, Trentin L, Herzig J, et al. Migration of acute lymphoblastic leukemia cells into the central nervous system is regulated by VEGF. Blood. 2015;126(23):2634–2634.
   Web of Science ®Google Scholar
• Ramirez M, Gomez A, Martinez C, et al. Chemokines in leukemic infiltration of the central nervous system in childhood acute lymphoblastic leukemia. Blood. 2009;114(22):1627–1627.
   Web of Science ®Google Scholar
• Frishman-Levy L, Shemesh A, Bar-Sinai A, et al. Central nervous system acute lymphoblastic leukemia: role of natural killer cells. Blood. 2015;125(22):3420–3431.
   PubMed Web of Science ®Google Scholar